News

Metabolic fingerprinting in multiple body fluids of a smoking cessation study showed quitting helps reverse smoking-related changes.

Appointment supports growth of the Company and expansion of expertise in integrated drug discovery and development.

Gyros Protein Technologies becomes distributor of iLite cell-based reporter gene assays for drug development.

Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that last for at least one year.

Cone snails, whose venom has similarities to lionfish and bee venoms, may hold the key to treating Parkinson's disease and drug addiction.

Successful completion of iPSC screening campaign.

New two-step process, improves neuronal stem cell assays.

Human lung-on-a-chip technology is used to study behavior and drug responses of lung cancer in its natural environment, uncovering key mechanical dependencies.

Rodent gastric bypass models, state-of-the-art mass spectrometry and an array of bioinformatics tools begin unravelling how gastric bypass surgery leads to weight loss and a resolution of type 2 diabetes.

Researchers have designed a smart bandage that could eventually heal chronic wounds or battlefield injuries with every fiber of its being. A single bandage could accommodate multiple medications tailored to a specific type of wound.